Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, Membranoproliferative

Explore clinical trials studying Glomerulonephritis, Membranoproliferative. Study availability and eligibility vary by location and protocol.

23 public trials 6 recruiting studies

Glomerulonephritis, Membranoproliferative trial results

Conditions
Autoimmune Diseases, Complement 3 Glomerulopathy (C3G), Female Urogenital Diseases, +12 more
Locations
  • ADARx Clinical Site Shenzhen, Guangdong, China
  • ADARx Clinical Site Guiyang, Guizhou, China
  • ADARx Clinical Site Zhengzhou, Henan, China
  • ADARx Clinical Site Baotou, Inner Mongolia, China
Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +18 more
Locations
  • Novartis Investigative Site São Paulo, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Ostrava, Poruba, Czechia
Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Academic Medical Research Institute (01034) Los Angeles, California, United States
  • Children's Hospital Colorado (01037) Aurora, Colorado, United States
  • University of Florida, Department of Pediatric Nephrology (01010) Gainsville, Florida, United States
  • Emory Investigational Drug Service (01021) Atlanta, Georgia, United States
View all 47 locations
Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • University Medical Center Groningen Groningen, Netherlands
  • Leiden University Medical Center Leiden, Netherlands
  • Radboud University Medical Center Nijmegen, Netherlands
  • HagaZiekenhuis The Hague, Netherlands